Related Experiment Videos

Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients

Insights

Peritoneal macrophages in dialysis patients show impaired defense against Candida albicans, leading to poor fungal killing. Dialysis fluid lacks immune factors, increasing candidal peritonitis risk.

Area of Science:

  • Immunology
  • Microbiology
  • Nephrology

Background:

  • Candidal peritonitis is a severe complication in chronic peritoneal dialysis patients.
  • Host defense mechanisms in the human peritoneal cavity against fungal infections are poorly understood.

Purpose of the Study:

  • To investigate the interaction between peritoneal macrophages (PM phi) from dialysis patients and Candida albicans.
  • To assess the candidacidal activity and respiratory burst of these macrophages.

Main Methods:

  • Chemiluminescence (CL) techniques were used to measure respiratory burst activity.
  • A fluorochrome microassay evaluated candidacidal activity.
  • Comparison of peritoneal macrophages with peripheral blood polymorphonuclear leukocytes (PMNs) from healthy donors.

Main Results:

  • Peritoneal macrophages (PM phi) exhibited significantly lower luminol-enhanced CL and killed fewer Candida cells (13%) compared to PMNs (35%).
  • Reduced myeloperoxidase levels and poor superoxide production were observed in PM phi during phagocytosis.
  • Peritoneal dialysis effluent lacked opsonic activity, which is crucial for PMN response to Candida.

Conclusions:

  • Local cellular and humoral defense mechanisms in the peritoneal cavity are inadequate in dialysis patients.
  • These deficiencies contribute to the susceptibility of patients to candidal peritonitis.

Related Concept Videos